Literature DB >> 6343888

Tolerance of T-cell clones is associated with membrane antigen changes.

E D Zanders, J R Lamb, M Feldmann, N Green, P C Beverley.   

Abstract

It is possible to regulate the activity of human influenza virus specific helper T-cell clones either by high concentrations of antigen or by anti-idiotypic suppressor T cells. In the absence of accessory cells, the appropriate peptide antigen recognized by the clones induces specific unresponsiveness. This phenomenon, however, is not the result of cytolysis as responsiveness to IL-2 remained unaltered. This suggests that high-dose immunological tolerance need not involve suppressor T cells, and that peptide antigens can interact directly with the T-cell surface. As recent reports suggest that the T-cell surface antigen T3 is involved in the triggering of T lymphocytes and possibly in antigen recognition we have investigated the expression of T3 and other cell surface antigens following the induction of T-cell tolerance. We report here that when a T-cell clone is exposed to a tolerizing concentration of the appropriate peptide antigen, surface T3 antigen is lost in a dose-dependent manner. As loss of surface T3 induced by anti-T3 antibody also results in unresponsiveness to antigen, we conclude that T3 is involved in the process of T-cell triggering by antigen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343888     DOI: 10.1038/303625a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

1.  Selective manipulation of the human T-cell receptor repertoire expressed by thymocytes in organ culture.

Authors:  M Merkenschlager; A G Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Authors:  S D Sharma; B Nag; X M Su; D Green; E Spack; B R Clark; S Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  On the Mechanism of T cell receptor down-modulation and its physiological significance.

Authors:  David Escors; Christopher Bricogne; Frederick Arce; Grazyna Kochan; Katarzyna Karwacz
Journal:  J Biosci Med       Date:  2011-01

4.  Stimulation of T cells through the CD3/T-cell receptor complex: role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway.

Authors:  J A Ledbetter; L E Gentry; C H June; P S Rabinovitch; A F Purchio
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

5.  Adipose tissue dendritic cell signals are required to maintain T cell homeostasis and obesity-induced expansion.

Authors:  Cara E Porsche; Jennifer B Delproposto; Elise Patrick; Brian F Zamarron; Carey N Lumeng
Journal:  Mol Cell Endocrinol       Date:  2020-01-24       Impact factor: 4.102

Review 6.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

7.  Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.

Authors:  R B Mannon; B L Kotzin; C Nataraj; K Ferri; E Roper; R J Kurlander; T M Coffman
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 8.  ZAP70: a master regulator of adaptive immunity.

Authors:  Alain Fischer; Capucine Picard; Karine Chemin; Stéphanie Dogniaux; Françoise le Deist; Claire Hivroz
Journal:  Semin Immunopathol       Date:  2010-02-05       Impact factor: 9.623

9.  Decreased expression of CD7 occurs in rheumatoid arthritis.

Authors:  A I Lazarovits; J Karsh
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.